This was the stock's second consecutive day of losses.

The stock's fall snapped a two-day winning streak.

Oppenheimer analyst Jeff Jones reiterated a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) today and set a price target of ...

CRB-701 Nectin-4 targeting ADC demonstrates encouraging results in Phase 1 Western studyFast Track Designation granted by FDA for CRB-701 to ...

NORWOOD, Mass. (AP) — NORWOOD, Mass. (AP) — Corbus Pharmaceuticals Holdings Inc. (CRBP) on Tuesday reported a loss of $9.5 million in its fourth quarter. The Norwood, Massachusetts-based ...

Local government crews in Washington began on Monday morning to remove the Black Lives Matter mural that was painted near the White House nearly five years ago. Errin Haines discusses.March 11, 2025 ...

From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...

Shares of NASDAQ CRBP opened at $6.79 on Monday. Corbus Pharmaceuticals has a twelve month low of $6.54 and a twelve month high of $61.90. The firm has a market cap of $82.70 million, a P/E ratio ...

SYMBOL - 23 April 2024, Baden-Württemberg, Rottweil: The logos of the cryptocurrencies Bitcoin ... [+] (BTC), Ethereum (ETH), the stablecoin Tether (USDT) and Binance Coin (BNB) can be seen on ...

NASDAQ CRBP opened at $6.79 on Thursday. Corbus Pharmaceuticals has a 12 month low of $6.54 and a 12 month high of $61.90. The stock’s fifty day moving average price is $9.98 and its 200-day ...